Brain immune cells exhibit profound gender differences that could explain why neurodegenerative diseases and cognitive aging affect men and women differently. These cellular variations may be locked in during the first days of life by hormone exposure, potentially influencing brain health for decades.
Rat studies reveal that testosterone administered within 24 hours of birth permanently altered female brain microglia—specialized immune cells that maintain neural health and respond to threats. These masculinized females retained male-like microglial characteristics through adolescence, adulthood, and into advanced age at 700 days old. The hormone treatment also produced lasting physical changes including larger body size and altered reproductive anatomy. Conversely, blocking testosterone in newborn males with flutamide created more modest feminization effects on their brain immune cells.
This research illuminates a critical window where hormones establish lifelong patterns in neuroinflammation and immune surveillance. Microglia shape synaptic pruning during development, clear cellular debris, and coordinate inflammatory responses throughout life. Their sex-specific programming could explain gender disparities in Alzheimer's disease prevalence, autism spectrum disorders, and depression rates. The findings suggest that prenatal or early postnatal hormone disruptions—from environmental chemicals, medications, or stress—might have far-reaching consequences for brain aging trajectories. However, this represents early-stage animal research requiring human validation. The work adds compelling evidence that fundamental aspects of brain health and disease susceptibility are established in the opening hours of life, when hormonal environments sculpt immune cell identity with remarkable permanence.